Cannabis is legal in Switzerland for medical purposes and the country is currently running seven pilot trials for adult-use cannabis with around 104,000 active participants as of June 2025. Switzerland is also in the process of drafting a new law that if approved would legalize adult-use cannabis use and establish a regulated commercial market.
Read more ›
1. Understand the regulatory and legal requirements. Do market research. Cannabis Legalization In Switzerland, medical cannabis is regulated by the […]
Read more ›
As of March 2026, some form of medical cannabis (or cannabis-based medicine) is legal in 25 countries across the region, with a further 9 having decriminalised the personal use of cannabis, and 4 having legalised cannabis for recreational use. The European cannabis market grew from €870 million in 2024 to €1.45 billion in 2025 and is projected to surpass €2 billion by 2027.
Read more ›
1. Understand the regulatory and legal requirements. Do market research. Australia Cannabis Legalization The Narcotic Drugs Amendment Bill was passed […]
Read more ›
With domestic cannabis production surging by 154% and imports skyrocketing by 959% – alongside exponential growth in patient prescriptions – demand for medical cannabis in Australia appears to be strong and poised for sustained upward momentum.
Read more ›
New Zealand’s medical cannabis supply has surged in recent years with THC-dominant products now making up the majority of prescriptions. The country’s cannabis industry – including the potential adult-use market – could be worth more than $1.5 billion.
Read more ›